Dr. Benjamin Hibbert, MD
Claim this profileOttawa Heart Institute
Studies Mitral Valve Regurgitation
Studies Atrial Fibrillation
8 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Benjamin Hibbert, MD is currently running
PFO Closure Devices
for Stroke Prevention
The objective of this study is to investigate whether percutaneous PFO closure with the Occlutech Flex II PFO Occluder is non-inferior to the AMPLATZER™ PFO Occluder and Gore® Cardioform Septal Occluder in closure of the PFO, prevention of recurrent embolic stroke, and device/procedure related Serious Adverse Events (SAE).
Recruiting1 award N/A4 criteria
Mitral Valve Repair vs. MitraClip Implantation
for Mitral Valve Regurgitation
The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.
Recruiting1 award N/A6 criteria
More about Benjamin Hibbert, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Benjamin Hibbert, MD has experience with
- Tendyne Mitral Valve System
- MitraClip System
- Apixaban
- Rivaroxaban
- Edwards Transcatheter Atrial Shunt System
- MitraClip™ Device Implantation
Breakdown of trials Benjamin Hibbert, MD has run
Mitral Valve Regurgitation
Atrial Fibrillation
Mitral Regurgitation
Heart Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Hibbert, MD specialize in?
Benjamin Hibbert, MD focuses on Mitral Valve Regurgitation and Atrial Fibrillation. In particular, much of their work with Mitral Valve Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Benjamin Hibbert, MD currently recruiting for clinical trials?
Yes, Benjamin Hibbert, MD is currently recruiting for 6 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Hibbert, MD has studied deeply?
Yes, Benjamin Hibbert, MD has studied treatments such as Tendyne Mitral Valve System, MitraClip System, Apixaban.
What is the best way to schedule an appointment with Benjamin Hibbert, MD?
Apply for one of the trials that Benjamin Hibbert, MD is conducting.
What is the office address of Benjamin Hibbert, MD?
The office of Benjamin Hibbert, MD is located at: Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7 Canada. This is the address for their practice at the Ottawa Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.